ALLURION TECHNOLOGIES, INC.
Close on Oct 19, 2026
- Market cap
- $6.34M
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Quarterly results announced on Form 8-K, Item 2.02
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q4 FY2025 Ended Dec 31, 2025 | Jan 12, 2026 | After market close | – | – | – |
| Q3 FY2025 Ended Sep 30, 2025 | Nov 12, 2025 | Before market open | $2.70M | $-1.53 | – |
| Q2 FY2025 Ended Jun 30, 2025 | Aug 13, 2025 | Before market open | $3.40M | – | – |
| Q1 FY2025 Ended Mar 31, 2025 | May 14, 2025 | Before market open | $5.60M | $0.20 | – |
| Q4 FY2024 Ended Dec 31, 2024 | Mar 26, 2025 | Before market open | $5.60M | $-7.95 | – |
| Q3 FY2024 Ended Sep 30, 2024 | Nov 13, 2024 | Before market open | $5.40M | $-0.14 | – |
| Q2 FY2024 Ended Jun 30, 2024 | Aug 13, 2024 | Before market open | $11.80M | – | – |
| Q1 FY2024 Ended Mar 31, 2024 | Apr 30, 2024 | Before market open | – | – | – |
| Q4 FY2023 Ended Dec 31, 2023 | Jan 8, 2024 | Before market open | – | – | – |
| Q3 FY2023 Ended Sep 30, 2023 | Nov 13, 2023 | Before market open | – | – | – |
Company guidance
Outlook given with results on May 14, 2025, compared with the previous outlook
| Measure | Period | Guidance | vs. prior |
|---|---|---|---|
| reduction in operating expenses | 2025 | 50% | New |
| revenue guidance | 2025 | $30.00M | New |
Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.
Press releases
Announcements Allurion Technologies filed with the SEC
Allurion Advances Plan to Re-List
Charter or bylaw amendment · Other events · EX-99.1 to Form 8-K
Allurion Advances Plan to Regain Listing Compliance
Listing notice · Other events · EX-99.1 to Form 8-K
Allurion Intends to Appeal NYSE Notice of Delisting While Executing Plan to Regain Compliance and Expects
Listing notice · Other events · EX-99.1 to Form 8-K
Allurion Receives U.S. FDA Approval for the Allurion Gastric Balloon System, Featuring the Allurion Smart Capsule
Regulation FD disclosure · EX-99.1 to Form 8-K
Allurion Announces Preliminary Fourth Quarter and Full-Year 2025 Results
Results of operations · EX-99.1 to Form 8-K
Allurion Reports Third Quarter 2025 Financial Results and Provides Business Update
Material agreement · Results of operations · Unregistered share sale · Other events · EX-99.1 to Form 8-K
Allurion Passes Critical FDA Milestones, Enters Into Transaction to Exchange All Outstanding Debt That Would Result in the Company Being
Material agreement · Results of operations · Unregistered share sale · Other events · EX-99.2 to Form 8-K
Allurion Reports Second Quarter 2025 Financial Results and Provides Business Update
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Allurion Announces New Strategic Direction With Increasing Focus on Low-Dose GLP-1 Combination Therapy, Muscle Mass Maintenance, and US Market Entry
Results of operations · Exit or restructuring costs · Regulation FD disclosure · EX-99.1 to Form 8-K
Allurion Reports First Quarter 2025 Financial Results and Provides Business Update
Results of operations · EX-99.1 to Form 8-K
Allurion Announces Postponement of Special Meeting of Stockholders
Other events · EX-99.1 to Form 8-K
Allurion Reports Fourth Quarter and Full-Year 2024 Financial Results
Results of operations · EX-99.1 to Form 8-K
Allurion to Raise Approximately $6.1 Million of Gross Proceeds in Offering and
Material agreement · Unregistered share sale · Other events · EX-99.1 to Form 8-K
Allurion Announces Closing of Offering and Concurrent Private
Material agreement · Unregistered share sale · Other events · EX-99.2 to Form 8-K
regulatory authority, clears Allurion to resume sales of the Allurion Balloon
Other events · EX-99.1 to Form 8-K
Allurion to Raise Approximately $7.4 Million of Gross Proceeds in
Material agreement · Unregistered share sale · Other events · EX-99.1 to Form 8-K
Allurion Announces Private Placement of Common Stock and
Material agreement · Results of operations · Unregistered share sale · EX-99.1 to Form 8-K
ALLURION TECHNOLOGIES, INC. AND SUBSIDIARIES
Material agreement · Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
ALLURION TECHNOLOGIES, INC. AND SUBSIDIARIES
Material agreement · Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Material agreement · Results of operations · Regulation FD disclosure · EX-99.3 to Form 8-K
Allurion Technologies, Inc. Announces Reverse Stock Split
Charter or bylaw amendment · Other events · EX-99.1 to Form 8-K
Allurion Reports Third Quarter 2024 Financial Results and Provides Business Update
Results of operations · EX-99.1 to Form 8-K
Allurion Receives Continued Listing Standards Notice from NYSE
Listing notice · Regulation FD disclosure · EX-99.1 to Form 8-K
Allurion Receives Continued Listing Standards Notice from NYSE
Listing notice · Regulation FD disclosure · EX-99.1 to Form 8-K
Allurion Reports Second Quarter 2024 Financial Results and Provides Business Update
Results of operations · EX-99.1 to Form 8-K
Allurion Announces Pricing of $20 Million Public Offering and Concurrent Private Placement
Material agreement · Unregistered share sale · Charter or bylaw amendment · Other events · EX-99.1 to Form 8-K
Allurion Reports First Quarter 2024 Financial Results and Provides Business Update
Results of operations · EX-99.1 to Form 8-K
Allurion Announces Preliminary First Quarter 2024 Results
Results of operations · EX-99.1 to Form 8-K
Allurion Closes $48 Million Convertible Senior Secured Note Financing
Material agreement · Agreement terminated · Unregistered share sale · Regulation FD disclosure · EX-99.1 to Form 8-K
Allurion Reports Fourth Quarter and Full Year 2023 Financial Results and Reiterates 2024 Guidance
Results of operations · EX-99.1 to Form 8-K
Allurion Announces Preliminary Fourth Quarter and Full Year 2023 Results and Provides 2024 Outlook
Results of operations · EX-99.1 to Form 8-K
Allurion Reports Third Quarter 2023 Financial Results and Provides Business Update
Results of operations · EX-99.1 to Form 8-K